Montis Capital

Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Datavail Corporation specializes in remote database management and application management services, helping businesses minimize downtime and focus on their core operations. Established in 2001 and headquartered in Broomfield, Colorado, with an additional office in Mumbai, India, the company offers a comprehensive range of solutions including database administration, cloud migration, application development, and infrastructure management. Its services encompass design and architecture, outsourcing, staff augmentation, monitoring, incident management, and recovery, ensuring that clients receive robust support for their data needs. Datavail aims to provide seamless management of data and applications, enabling organizations to operate efficiently without the burden of technical complexities.